Evidence map›Paper›PMID 21813709›Full record

ArticleAmerican journal of physiology. Cell physiology2011

With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume.

Brian R Haas, Vishnu A Cuddapah, Stacey Watkins, Katie Jo Rohn, Tiffany E Dy, Harald Sontheimer

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Role of Ion-Transporting Proteins in Human Disease.International journal of molecular sciences · 2024
    Article
  8. Review
  9. Physiological roles of chloride ions in bodily and cellular functions.The journal of physiological sciences : JPS · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Role of NKCC1 Activity in Glioma KFrontiers in physiology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Brian R HaasDepartment of Neurobiology and the Center for Glial Biology in Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Vishnu A Cuddapah
Stacey Watkins
Katie Jo Rohn
Tiffany E Dy
Harald Sontheimer
University of Alabama at Birmingham · US

Funding

PHS HHS R01-031234PHS HHS R01-036692
6 · The paper itself

Abstract

Among the most prevalent and deadly primary brain tumors, high-grade gliomas evade complete surgical resection by diffuse invasion into surrounding brain parenchyma. Navigating through tight extracellular spaces requires invading glioma cells to alter their shape and volume. Cell volume changes are achieved through transmembrane transport of osmolytes along with obligated water. The sodium-potassium-chloride cotransporter isoform-1 (NKCC1) plays a pivotal role in this process, and previous work has demonstrated that NKCC1 inhibition compromises glioma invasion in vitro and in vivo by interfering with the required cell volume changes. In this study, we show that NKCC1 activity in gliomas requires the With-No-Lysine Kinase-3 (WNK3) kinase. Western blots of patient biopsies and patient-derived cell lines shows prominent expression of Ste-20-related, proline-alanine-rich kinase (SPAK), oxidative stress response kinase (OSR1), and WNK family members 1, 3, and 4. Of these, only WNK3 colocalized and coimmunoprecipitated with NKCC1 upon changes in cell volume. Stable knockdown of WNK3 using specific short hairpin RNA constructs completely abolished NKCC1 activity, as measured by the loss of bumetanide-sensitive cell volume regulation. Consequently, WNK3 knockdown cells showed a reduced ability to invade across Transwell barriers and lacked bumetanide-sensitive migration. This data indicates that WNK3 is an essential regulator of NKCC1 and that WNK3 activates NKCC1-mediated ion transport necessary for cell volume changes associated with cell invasion.

Indexed as

Brain NeoplasmsBumetanideCell Line, TumorCell SizeGliomaHumansIntracellular Signaling Peptides and ProteinsMinor Histocompatibility AntigensNeoplasm InvasivenessProtein Serine-Threonine KinasesRNA, Small InterferingSodium Potassium Chloride Symporter InhibitorsSodium-Potassium-Chloride SymportersSolute Carrier Family 12, Member 2WNK Lysine-Deficient Protein Kinase 1BumetanideIntracellular Signaling Peptides and ProteinsMinor Histocompatibility AntigensOXSR1 protein, humanProtein Serine-Threonine KinasesRNA, Small InterferingSLC12A2 protein, humanSodium Potassium Chloride Symporter InhibitorsSodium-Potassium-Chloride SymportersSolute Carrier Family 12, Member 2STK39 protein, humanWNK1 protein, humanWNK3 protein, humanWNK4 protein, humanWNK Lysine-Deficient Protein Kinase 1

Identifiers

PMID21813709
PMCPMC3213919
OpenAlexW2144321636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.